Population: 11 US-listed companies (SIC 2835), fiscal year 2022; fiscal year ends 2022-09-30 to 2023-05-31.
Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest
| 10th percentile | -377.2% |
|---|---|
| 25th percentile | -123.0% |
| Median | -2.5% |
| 75th percentile | 18.3% |
| 90th percentile | 30.0% |
| Mean | -126.6% |
| Minimum | -864.5% |
| Maximum | 34.5% |
Latest EBITDA Margin percentiles (live) · All In Vitro & In Vivo Diagnostic Substances benchmarks · All industries
Cite as: FACTANKER, https://factanker.com/industries/sic-2835/ebitda-margin/2022